Batelapine maleate

This classification denotes the maleate form of an antipsychotic agent with the molecular structure C16H20N6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, P71TE299SG chemically known as 11h-(1,2,4)triazolo(1,5-c)(1,3)benzodiazepine, 2-methyl-5-(4-methyl-1-piperazinyl)-, but more commonly known as batelapine, which bears US NIH Compound Identifier 60717. European Medicines Agency schedules Batelapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06110MIG. The term BATELAPINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 5, no. 3 1991, list 31. ). Most nations, for tariff and trade purposes, schedule batelapine maleate under HS 29335995 and SITC 51576. As of Q4 2014, BATELAPINE MALEATE remains US FDA's Preferred Term for this commodity. Batelapine maleate bears US NLM identifiers UMLS ID C2698335 and NCI Concept Code C76437. SMILES: CC1NC2N(N1)C(=NC3CCCCC3C2)N4CCN(CC4)C.C(=C\C(=O)O)\C(=O)O.